$RXRX has been mentioned 32 times over the past 12 months by 6 distinct FinTwit voices, with the first mention appearing on November 5, 2025. The most-active voice discussing the stock is @investmentguru_, who accounts for 24 of these mentions, followed by @midascabal with 3 mentions and @alphatica with 2 mentions. The long research category dominates discussion of $RXRX among these voices, reflecting analytical focus on the company's positioning.

@investmentguru_ featured $RXRX most recently on July 15, 2026, listing it among "The Best Multi-Year Bets in This Market" alongside $QS, $SMR, $JOBY, and others. In an earlier post from July 1, 2026, @investmentguru_ characterized $RXRX as a company that "Uses AI and automation to accelerate drug discovery at scale," including it in a curated list of top biotechnology stocks as part of broader commentary on biotech sector strength.